Perspective Therapeutics (NYSE:CATX) Earns Outperform Rating from Wedbush
Perspective Therapeutics (NYSE:CATX – Get Free Report)‘s stock had its “outperform” rating reaffirmed by equities researchers at Wedbush in a report issued on Thursday,RTT News reports. They currently have a $11.00 price target on the stock, down from their prior price target of $20.00. Wedbush’s price target suggests a potential upside of 265.45% from the […]
More Stories
Sparta Commercial Services (OTCMKTS:SRCO) Issues Earnings Results
Sparta Commercial Services (OTCMKTS:SRCO – Get Free Report) announced its quarterly earnings results on Monday. The financial services provider reported...
Over 207 executed in Port-au-Prince massacre: UN report
A little over two weeks after a surge of violence in the Cité Soleil commune of Haiti’s capital, Port-au-Prince, a...
Consumer Confidence Falls Amid Pessimism About Future Economy and Employment
By Tom Ozimek Confidence among U.S. consumers slumped in December, driven by growing pessimism about future economic and labor market...
Dudley & Shanley Inc. Sells 166,940 Shares of Wheaton Precious Metals Corp. (NYSE:WPM)
Dudley & Shanley Inc. lessened its stake in shares of Wheaton Precious Metals Corp. (NYSE:WPM – Free Report) by 11.7%...
Dudley & Shanley Inc. Has $15.58 Million Position in The Charles Schwab Co. (NYSE:SCHW)
Dudley & Shanley Inc. boosted its position in shares of The Charles Schwab Co. (NYSE:SCHW – Free Report) by 2.1%...
Indus Gas (LON:INDI) Stock Price Up 38.4% – Should You Buy?
Indus Gas Limited (LON:INDI – Get Free Report) rose 38.4% on Monday . The stock traded as high as GBX...